DOMOSO Solution Canada - français - Health Canada

domoso solution

zoetis canada inc - diméthylsulfoxyde - solution - 90% - diméthylsulfoxyde 90% - chevaux; chiens

DIMETHYL SULFOXIDE IRRIGATION USP Solution Canada - français - Health Canada

dimethyl sulfoxide irrigation usp solution

sandoz canada incorporated - diméthylsulfoxyde - solution - 500mg - diméthylsulfoxyde 500mg - miscellaneous therapeutic agents

RIMSO-50 Solution Canada - français - Health Canada

rimso-50 solution

mylan pharmaceuticals ulc - diméthylsulfoxyde - solution - 500mg - diméthylsulfoxyde 500mg - miscellaneous therapeutic agents

KEMSOL LIQUID 70% Solution Canada - français - Health Canada

kemsol liquid 70% solution

axxess pharma inc. - diméthylsulfoxyde - solution - 70% - diméthylsulfoxyde 70% - miscellaneous therapeutic agents

DOMOSO GEL 90% Canada - français - Health Canada

domoso gel 90%

syntex animal health, division of syntex inc. - diméthylsulfoxyde - gel - 90% - diméthylsulfoxyde 90% - objet - chevaux

DOMOSO SOLN 90% Liquide Canada - français - Health Canada

domoso soln 90% liquide

syntex animal health, division of syntex inc. - diméthylsulfoxyde - liquide - 90% - diméthylsulfoxyde 90% - objet - chiens; chevaux

DOMOSO Gel Canada - français - Health Canada

domoso gel

pfizer canada inc animal health group - diméthylsulfoxyde - gel - 90% - diméthylsulfoxyde 90% - chevaux

SYNOTIC Solution Canada - français - Health Canada

synotic solution

zoetis canada inc - diméthylsulfoxyde; acétonide de fluocinolone - solution - 60%; 0.01% - diméthylsulfoxyde 60%; acétonide de fluocinolone 0.01% - chiens

SYNOTIC OTIC SOLUTION Canada - français - Health Canada

synotic otic solution

syntex animal health, division of syntex inc. - acétonide de fluocinolone; diméthylsulfoxyde - solution - 0.01%; 60% - acétonide de fluocinolone 0.01%; diméthylsulfoxyde 60% - objet - chien ou chat

Tecartus Union européenne - français - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymphome, cellule du manteau - agents antinéoplasiques - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).